Latest AI and machine learning research in breast cancer for healthcare professionals.
Organisation and dynamics of chromatin play a key role in regulation of cell state and function. In cancer, chromatin plasticity is known to be important in control of drug resistance, but the relationship between chromatin compaction and chemotherapy response within complex tissue settings remains unclear. Here, we measured single nuclei chromatin compaction using fluorescence lifetime imaging mi...
Acute myeloid leukemia (AML) often enters remission after chemotherapy but frequently relapses due to chemotherapy-resistant leukemic stem cells (LSCs). Relapsed AML remains largely unresponsive to current therapies and carries a poor prognosis. We developed a large-language model (LLM) agent that incorporates multi-modal data to nominate druggable therapeutic targets for AML. We identified that h...
Artificial intelligence (AI)-based imaging analysis has applications for the diagnosis of head and neck malignancies, and serum circulating tumor-asso...
Given the high prevalence of vertebral fractures post-radiotherapy in patients with metastatic spine disease, accurate and rapid muscle segmentation c...
While mammography is commonly used for breast cancer detection, its widespread implementation in resource-constrained nations is challenging. Artifici...
HER2 expression level is a key factor in determining the optimal treatment course for breast cancer patients. Roughly 15% of breast cancers are HER2(+...
Artificial intelligence (AI) foundation models such as Segment Anything Model 2 (SAM 2) offer potential for semi-automated image segmentation with min...
Conventional chemotherapeutics exploit cancer’s hallmark of active cell cycling, primarily targeting mitotic cells. Consequently, the mitotic index (M...
The prognostic significance of tumor-infiltrating lymphocytes (TILs) in breast cancer has been recognized for over a decade. Although histology-based ...
In the field of medical crowdfunding prediction, traditional statistical methods have long been the standard. Machine learning algorithms are popular ...
Introduction: Achieving equity in translational precision medicine requires the integration of genomic, clinical, and social determinants of health (S...
Human epidermal growth factor receptor 2 (HER2) expression is a critical biomarker for assessing breast cancer (BC) severity and guiding targeted anti...
Genomic testing has transformed treatment decisions for hormone receptor-positive, HER2-negative (HR+/HER2-) early breast cancer; however, it remains ...
Muscle-invasive bladder cancer (MIBC) is associated with poor predictability of response to cisplatin-based neoadjuvant chemotherapy (NAC). Consequent...
Late radiation-associated dysphagia after head and neck cancer (HNC) significantly impacts patient’s health and quality of life. Conventional normal t...
Glaucoma is increasingly recognized as a neurodegenerative condition involving both retinal and central nervous system structures. Here, we present an...
The RTK-RAS signaling cascade is a central axis in colorectal cancer (CRC) pathogenesis, governing cellular proliferation, survival, and therapeutic r...
This study addresses the critical implementation science challenge of operationalizing social determinants of health (SDoH) in clinical practice. We d...
Large language models are increasingly used to generate patient information in healthcare. However, their ability to communicate complex topics, such ...
The OncotypeDX 21-gene assay is a widely adopted tool for estimating recurrence risk and informing chemotherapy decisions in early-stage, hormone rece...